Effect of visfatin on the function of endothelial progenitor cells in high-fat-fed obese rats and investigation of its mechanism of action

International Journal of Molecular Medicine

Volumn 30, Issue 3, 2012, Pages 622-628

  Sun, Yang ^a,b,c   Chen, Shuchun ^a,b   Song, Guangyao ^a,b   Ren, Luping ^a,b   Wei, Limin ^a,b   Liu, Na ^a,b   Zhang, Donemei ^a,b   Lv, Xiuqin ^a,b  

^a HEBEI GENERAL HOSPITAL   (China)

^b Hebei Research Institute for Endocrine and Metabolic Diseases   (China)

^c Taishan Sanatorium of Shandong ^*  (China)

Author keywords

Endothelial progenitor cells; Obesity; Visfatin

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET RESTRICTION; DRUG MECHANISM; ENDOTHELIAL PROGENITOR CELL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID DIET; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL CULTURE TECHNIQUES; DIET, HIGH-FAT; ENDOTHELIAL CELLS; IMMUNOPHENOTYPING; INTRA-ABDOMINAL FAT; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RATS; RATS, WISTAR; STEM CELLS;

EID: 84865159145     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1032     Document Type: Article

References (46)

1. Laufs U, Urhausen A, Werner N, et al: Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 12: 407-414, 2005. (Pubitemid 41192175)
2. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003. (Pubitemid 36204953)
3. Fadini GP, Miorin M, Facco M, et al: Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45: 1449-1457, 2005. (Pubitemid 40615617)
4. Fadini GP, Sartore S, Albiero M, et al: Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140-2146, 2006. (Pubitemid 44253800)
5. Fadini GP, Sartore S, Agostini C and Avogaro A: Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30: 1305-1313, 2007. (Pubitemid 46684670)
6. Meyers MR and Gokce N: Endothelial dyfuntion in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 14: 365-369, 2007. (Pubitemid 47368087)
7. Reriani MK, Lerman LO and Lerman A: Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 4: 351-360, 2010.
8. Chung IM, Kim YM, Yoo MH, et al: Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway. Atherosclerosis 213: 109-114, 2010.
9. Sitia S, Tomasoni L, Atzeni F, et al: From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9: 830-834, 2010.
10. Kouidhi S, Jarboui S, Marrakchi R, et al: Adiponectin expression and metabolic markers in obesity and type 2 diabetes. J Endocrinol Invest 34: e16-e23, 2011.
11. Mangge H, Almer G, Truschnig-Wilders M, et al: Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 17: 4511-4520, 2010.
12. Yun JE, Kimm H, Jo J and Jee SH: Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations. Metabolism 59: 424-429, 2010.
13. Hecker PA, O'Shea KM, Galvao TF, et al: Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice. Horm Metab Res 43: 100-105, 2011.
14. Chang J, Li Y, Huang Y, et al: Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes 59: 2949-2959, 2010.
15. Lavoie V, Kernaleguen AE, Charron G, et al: Functional effects of adiponectin on endothelial progenitor cells. Obesity 19: 722-728, 2011.
16. Moschen AR, Kaser A, Enrich B, et al: Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178: 1748-1758, 2007. (Pubitemid 46154646)
17. Lee WJ, Wu CS, Lin H, et al: Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway. Int J Obes 33: 465-472, 2009.
18. Huang F, Xiong XF, You S, et al: Visfatin upregulates MMP-2 and MMP-9 expressions in human monocytes through activating NF-kappaB. Zhonghua Xin Xue Guan Bing Za Zhi 38: 455-459, 2010 (In Chinese).
19. Kim SR, Bae YH, Bae SK, et al: Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 1783: 886-895, 2008.
20. Chang YC, Chang TJ, Lee WJ and Chuang LM: The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Metabolism 59: 93-99, 2010.
21. Kang YS, Song HK, Lee MH, et al: Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients. Diabetes Res Clin Pract 89: 141-149, 2010.
22. Dogru T, Sonmez A, Tasci I, et al: Plasma visfatin levels in patients with newly diagnosed and untreated type2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 76: 24-29, 2007. (Pubitemid 46240362)
23. Fukuhara A, Matsuda M, Nishizawa M, et al: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005. (Pubitemid 40139988)
24. Takebayashi K, Suetsugu M, Wakabyashi S, et al: Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 56: 451-458, 2007. (Pubitemid 46427838)
25. Adya R, Tan BK, Chen J and Randeva HS: Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: role in MMP-2/9 production and activation. Diabetes Care 31: 758-760, 2008.
26. Doupis J, Rahangdale S, Gnardellis C, et al: Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity 19: 729-735, 2011.
27. Yan LL, Daviglus ML, Liu K, et al: Midlife body mass index and hospitalization and mortality in older age. JAMA 295: 190-198, 2006. (Pubitemid 43076438)
28. Akil L and Ahmad HA: Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved 22 (Suppl 4): 61-72, 2011.
29. DeClercq V, Taylor C and Zahradka P: Adipose tissue: the link between obesity and cardiovascular disease. Cardiovasc Hematol Disord Drug Targets 8: 228-237, 2008.
30. Barton M: Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch 460: 825-837, 2010.
31. Kobayasi R, Akamine EH, Davel AP, et al: Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens 28: 2111-2119, 2010.
32. Ketonen J, Shi J, Martonen E and Mervaala E: Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74: 1479-1487, 2010.
33. Short KR, Blackett PR, Gardner AW and Copeland KC: Vascular health in children and adolescents: effects of obesity and diabetes. Vasc Health Risk Manag 5: 973-990, 2009.
34. Heida NM, Müller JP, Cheng IF, et al: Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 55: 357-367, 2010.
35. MacEneaney OJ, Kushner EJ, Van Guilder GP, et al: Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. Int J Obes (Lond) 33: 219-225, 2009.
36. MacEneaney OJ, Kushner EJ, Westby CM, et al: Endothelial progenitor cell function, apoptosis, and telomere length in overweight/ obese humans. Obesity 18: 1677-1682, 2010.
37. Tobler K, Freudenthaler A, Baumgartner-Parzer SM, et al: Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond) 34: 687-700, 2010.
38. Westerweel PE, Visseren FL, Hajer GR, et al: Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur Heart J 29: 2808-2817, 2008.
39. Esposito K, Ciotola M, Maiorino MI, et al: Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. J Sex Med 6: 107-114, 2009.
40. Malyszko J, Malyszko JS and Mysliwiec M: Visfatin and endothelial function in dialyzed patients. Nephrology (Carlton) 15: 190-196, 2010.
41. Schutte AE, Huisman HW, Schutte R, et al: Adipokines and cardiometabolic function: How are they interlinked? Regul Pept 164: 133-138, 2010.
42. Moschen AR, Gerner RR and Tilg H: Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des 16: 1913-1920, 2010.
43. Moschen AR, Geiger S, Gerner R and Tilg H: Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat Res 690: 95-101, 2010.
44. Verma S, Kuliszewski MA, Li SH, et al: C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109: 2058-2067, 2004. (Pubitemid 38620212)
45. Suh W, Kim KL, Choi JH, et al: C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 321: 65-71, 2004. (Pubitemid 39055606)
46. Nan JL, Li JJ and He JG: C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway. Chin Med J (Engl) 122: 1922-1928, 2009.